AAMU
NVO

AEGON Asset Management (UK)’s Novo Nordisk NVO Stock Holding History

AEGON Asset Management (UK)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$3K Hold
36
– – ﹤0.01% 159
2023
Q1 		$3K Hold
36
– – ﹤0.01% 159
2022
Q4 		$2K Hold
36
– – ﹤0.01% 164
2022
Q3 		$2K Hold
36
– – ﹤0.01% 163
2022
Q2 		$2K Buy
+36
New +$2K ﹤0.01% 172

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AEGON Asset Management (UK)'s NVO Position: Q2 2023 in Review

AEGON Asset Management (UK) held its Novo Nordisk (NVO) position steady in Q2 2023 at 36 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #159.

AEGON Asset Management (UK) first reported a position in NVO in Q2 2022 and has held it in 5 quarters since. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • AEGON Asset Management (UK) held 36 shares of Novo Nordisk worth $3K as of Q2 2023.
  • AEGON Asset Management (UK) left its Novo Nordisk share count unchanged in Q2 2023.
  • Novo Nordisk made up ﹤0.01% of AEGON Asset Management (UK)'s portfolio in Q2 2023, its #159 holding.
  • AEGON Asset Management (UK) first reported a position in Novo Nordisk in Q2 2022 and has held it in 5 quarters since.
  • 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2023, filed 28 Jul 2023.